CDKN2A gene is one of the most frequent tumor suppressors genes altered between 50 and 80% of melanomas [9]; it encodes p16 and p14ARF proteins, which act as negative regulators in the transition of the G1/S and G2 phase of the cell cycle [10]. This evidence concerns the gene CDKN2A and melanoma.